under greenhouse conditions. The optimal treatment (200 mg/L) reduced disease severity by 42.6% and outperformed ionic Ca and P controls, as well as a commercial fungicide. Mechanistically, nHAP exhibited superior foliar retention (6.88%), enhancing local Ca and P bioavailability, and reshaping the phyllosphere microbiome by enriching beneficial and phosphate-solubilizing bacteria. These shifts were associated with a 23.5% increase in salicylic acid biosynthesis relative to that of the infected control and activation of systemic acquired resistance. Metabolomic analysis further revealed an enhanced energy metabolism and secondary metabolite biosynthesis. In addition, nHAP increased grain yield by 51.9% and improved grain nutritional quality (e.g., starch and protein) by 40.5-63.0%. These findings support nHAP as a promising strategy for sustainable crop-disease management and food production.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: